1. Home > Interviews >

New Challenges for Levofloxacin in the Fight Against Infectious Diseases (Interviews with World-Renowned Experts)

21 June, 2018

 

bar
drusana Pharmacokinetic/Pharmacodynamic Breakpoints: Time to Consider New Parameters of Antimicrobial Efficacy

George L. Drusano, MD

 start
Role of Levofloxacin in the Treatment of Rhinosinusitis

Michael D. Poole, MD, PhD

 start
ball Role of Levofloxacin in the Treatment of Lower Respiratory Tract Infections

Peter Ball, FRCP (Ed)

 start


LATEST TOPICS

Managing Infectious Diseases in Emergency Medicine: A Specialist’s Approach
10 April, 2024
Advancing standardised diagnosis and treatment of acute infectious disease: Insights from an expert in theory–technique integration
08 April, 2024
Managing severe infections: Practical approaches for antibiotic use, including combination therapy
05 March, 2024
Updating Traditional Approaches: Expert Insights on Addressing Urinary Tract Infections
26 February, 2024
Antibiotic resistance may be driven by diverse factors, including extreme climatic events
14 February, 2024

RELATED ARTICLES

Antimicrobial resistance in respiratory tract infections: Current trends and strategies
06 August, 2021
Under the new medical reform, there are challenges for the rational use of antibiotics, making it necessary to adopt coping strategies
20 April, 2023
Professional Insights: Navigating Optimal Diagnosis and Treatment of Infectious Diseases in the Emergency Department
05 February, 2024
Community-acquired pneumonia: Insights into the current challenges and the role of levofloxacin
29 January, 2024
What is good clinical research?
03 October, 2022